Cargando…
Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide
PURPOSE: Use of the patient’s body surface area (mg m(−2)) as a basis for dosing does not take individual variation in metabolic capacity and rate of clearance into account. Here, we evaluated a novel approach for individual monitoring of short-lived cytotoxic agents formed from cytostatic drugs suc...
Autores principales: | von Stedingk, Hans, Xie, Hanjing, Hatschek, Thomas, Foukakis, Theodoros, Rydén, Andreas, Bergh, Jonas, Rydberg, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143677/ https://www.ncbi.nlm.nih.gov/pubmed/25053385 http://dx.doi.org/10.1007/s00280-014-2524-7 |
Ejemplares similares
-
Cyclophosphamide exposure assessed with the biomarker phosphoramide mustard-hemoglobin in breast cancer patients: The TailorDose I study
por: Gernaat, S. A. M., et al.
Publicado: (2021) -
Influence of Renal Function on Phosphoramide Mustard Exposure: A Nonlinear Mixed‐Effects Analysis
por: Jaber, Mutaz M., et al.
Publicado: (2022) -
Novel Sophoridine Derivatives Bearing Phosphoramide Mustard Moiety Exhibit Potent Antitumor Activities In Vitro and In Vivo
por: Li, Dongdong, et al.
Publicado: (2018) -
LC/MS/MS Analysis of N-Terminal Protein Adducts with Improved Sensitivity: A Comparison of Selected Edman Isothiocyanate Reagents
por: Rydberg, Per, et al.
Publicado: (2009) -
A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment
por: Browall, Maria, et al.
Publicado: (2016)